In HER2+ BC patients, a study of circulating EVs demonstrated an upregulated expression level of serum EV lncRNA SNHG14 (long non-coding-small nucleolar RNA host gene 14) in patients who exhibited resistance to trastuzumab, compared with patients who exhibited a response. The gene discussed is ERBB2; the disease is breast cancer.